IN8bio Inc.

NASDAQ: INAB · Real-Time Price · USD
2.35
-0.05 (-2.08%)
At close: Aug 15, 2025, 3:59 PM
2.37
0.85%
After-hours: Aug 15, 2025, 04:10 PM EDT

IN8bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
2.65M 2.5M 1.1M 251K
Gross Profit
-2.65M -2.5M -1.1M -251K
Operating Income
-29.6M -30.34M -28.52M -14.65M
Interest Income
230K n/a n/a n/a
Pretax Income
-30.44M -30.01M -28.52M -14.65M
Net Income
-30.44M -30.01M -28.52M -14.65M
Selling & General & Admin
12.64M 13.51M 14.46M 7.31M
Research & Development
16.96M 16.83M 14.06M 7.35M
Other Expenses
-2.65M -2.5M n/a n/a
Operating Expenses
26.94M 27.84M 28.52M 14.65M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
29.6M 30.34M 28.52M 14.65M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
53.55M 29.86M 20.97M 18.78M
Shares Outstanding (Diluted)
53.55M 29.86M 20.97M 18.78M
EPS (Basic)
-0.57 -1 -1.36 -0.78
EPS (Diluted)
-0.57 -1 -1.36 -0.78
EBITDA
-27.78M -27.51M -27.42M -14.4M
EBIT
-30.44M -30.01M -28.52M -14.65M
Depreciation & Amortization
2.65M 2.5M 1.1M 251K